Cheap, Safe Treatment Cuts Serious COVID-19 by 90%, Oxford Study Shows
An Oxford University study has confirmed the remarkable effectiveness of common asthma treatment Budesonide for treating COVID-19, reducing the risk of serious disease by 90% if taken at an early stage.
The post Cheap, Safe Treatment Cuts Serious COVID-19 by 90%, Oxford Study Shows appeared first on Lockdown Sceptics.
